29 related articles for article (PubMed ID: 18973858)
1. Two-dimensional imaging of tumour control probabilities and normal tissue complication probabilities.
Szlag M; Slosarek K
Rep Pract Oncol Radiother; 2010; 15(2):31-9. PubMed ID: 24376921
[TBL] [Abstract][Full Text] [Related]
2. Normal tissue complication probability: does simultaneous integrated boost intensity-modulated radiotherapy score over other techniques in treatment of prostate adenocarcinoma.
Basu KS; Bahl A; Subramani V; Sharma DN; Rath GK; Julka PK
J Cancer Res Ther; 2009; 5(2):78-84. PubMed ID: 19542662
[TBL] [Abstract][Full Text] [Related]
3. IMRT dose fractionation for head and neck cancer: variation in current approaches will make standardisation difficult.
Ho KF; Fowler JF; Sykes AJ; Yap BK; Lee LW; Slevin NJ
Acta Oncol; 2009; 48(3):431-9. PubMed ID: 18781445
[TBL] [Abstract][Full Text] [Related]
4. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
[TBL] [Abstract][Full Text] [Related]
5. Convex reformulation of biologically-based multi-criteria intensity-modulated radiation therapy optimization including fractionation effects.
Hoffmann AL; den Hertog D; Siem AY; Kaanders JH; Huizenga H
Phys Med Biol; 2008 Nov; 53(22):6345-62. PubMed ID: 18941280
[TBL] [Abstract][Full Text] [Related]
6. Comparison of traditional and simultaneous IMRT boost technique basing on therapeutic gain calculation.
Slosarek K; Zajusz A; Szlag M
Med Dosim; 2008; 33(4):299-302. PubMed ID: 18973858
[TBL] [Abstract][Full Text] [Related]
7. Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review.
Orlandi E; Palazzi M; Pignoli E; Fallai C; Giostra A; Olmi P
Crit Rev Oncol Hematol; 2010 Feb; 73(2):111-25. PubMed ID: 19409808
[TBL] [Abstract][Full Text] [Related]
8. Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.
Grégoire V
Rays; 2005; 30(2):105-8. PubMed ID: 16294902
[TBL] [Abstract][Full Text] [Related]
9. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
Jones B
J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiation therapy for head and neck carcinoma.
Grégoire V; De Neve W; Eisbruch A; Lee N; Van den Weyngaert D; Van Gestel D
Oncologist; 2007 May; 12(5):555-64. PubMed ID: 17522243
[TBL] [Abstract][Full Text] [Related]
11. [IMRT and head and neck tumors: does differential fractionation have a role?].
Giraud P; Servagi-Vernat S
Cancer Radiother; 2013 Oct; 17(5-6):502-7. PubMed ID: 23969241
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]